Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
51.02
+0.91 (1.82%)
May 27, 2026, 4:00 PM EDT - Market closed
Vaxcyte Market Cap
Vaxcyte has a market cap or net worth of $7.37 billion as of May 28, 2026. Its market cap has increased by 80.78% in one year.
Market Cap
7.37B
Enterprise Value
5.75B
1-Year Change
80.78%
Ranking
Category
Stock Price
$51.02
Market Cap Chart
Since June 15, 2020, Vaxcyte's market cap has increased from $1.38B to $7.37B, an increase of 433.87%. That is a compound annual growth rate of 32.51%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 27, 2026 | 7.37B | 21.97% |
| Dec 31, 2025 | 6.04B | -40.80% |
| Dec 31, 2024 | 10.20B | 70.74% |
| Dec 29, 2023 | 5.98B | 57.79% |
| Dec 30, 2022 | 3.79B | 201.58% |
| Dec 31, 2021 | 1.26B | -7.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 15, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nuvalent | 8.48B |
| ImmunityBio | 8.26B |
| Halozyme Therapeutics | 8.14B |
| Bio-Techne | 7.53B |
| Corcept Therapeutics | 7.15B |
| Immunovant | 6.86B |
| Kymera Therapeutics | 6.72B |
| Protagonist Therapeutics | 6.57B |